VASOACTING AGENTS FLAVONE ACETIC-ACID AND HYDRALAZINE GIVEN IN COMBINATION ENHANCE ANTITUMOR EFFECTS UNDER CONDITION OF HYPERTHERMIA

Citation
M. Yamamoto et al., VASOACTING AGENTS FLAVONE ACETIC-ACID AND HYDRALAZINE GIVEN IN COMBINATION ENHANCE ANTITUMOR EFFECTS UNDER CONDITION OF HYPERTHERMIA, Oncology, 53(2), 1996, pp. 147-152
Citations number
31
Categorie Soggetti
Oncology
Journal title
ISSN journal
00302414
Volume
53
Issue
2
Year of publication
1996
Pages
147 - 152
Database
ISI
SICI code
0030-2414(1996)53:2<147:VAFAAH>2.0.ZU;2-5
Abstract
The combined effects of flavone acetic acid (FAA), hydralazine (HYD) a nd hyperthermia on B16 melanoma cells and solid tumor were examined in vitro and in vivo. In vitro, hyperthermia did not enhance the cytotox icity of the combined use of FAA and HYD. In vivo, growth inhibition o f B16 melanoma solid tumor by FAA (150 mg/kg) combined with HYD (5.0 m g/kg) could not be differentiated from that by FAA or HYD alone. Incre ased antitumor effect was recognized when FAA combined with HYD was us ed under conditions of hyperthermia. FAA combined with HYD significant ly reduced tumor blood flow compared to FAA alone or HYD alone. We thu s conclude that the significant reduction in tumor blood flow may play an important role in the enhanced antitumor effects of the combined t reatment with FAA, HYD, and hyperthermia.